Mirae Asset Global Investments Co., Ltd. Procept Bio Robotics Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,774 shares of PRCT stock, worth $700,252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,774
Previous 393,540
97.77%
Holding current value
$700,252
Previous $19.4 Million
97.24%
% of portfolio
0.0%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$278 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$144 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$139 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$109 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.56B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...